Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Integral Diagnostics, often referred to as IDX, is a leading provider of medical imaging services with its headquarters proudly located in Australia. As a pivotal player in the "Other services" sector (specifically within healthcare), IDX delivers crucial diagnostic insights across Australia and New Zealand.
Established to offer high-quality radiology services, Integral Diagnostics has grown significantly, becoming a trusted name in the industry. They provide a comprehensive range of diagnostic imaging solutions, including X-rays, ultrasounds, CT scans, MRI scans, and nuclear medicine, utilising advanced technology and expert radiologists.
What sets Integral Diagnostics apart is their commitment to clinical excellence and patient care, combined with a focus on innovation in diagnostic pathways. Their prominent market position is a testament to their dedication to improving health outcomes through precise and timely diagnostics.
+13 vs industry average
Integral Diagnostics’s score of 37 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Other Services has below-average carbon intensity
The Other Services industry has reduced its overall emissions by 37% since 2018
Scope 3 accounts for ••• of total emissions.
Integral Diagnostics, headquartered in Australia and operating in the "Other services (93)" industry, reported total emissions of approximately 32,746,000 kg CO2e for 2025. This includes Scope 1 emissions of approximately 645,000 kg CO2e, Scope 2 market-based emissions of about 12,993,000 kg CO2e, and Scope 3 emissions of approximately 18,492,000 kg CO2e.
In the preceding year, 2024, Integral Diagnostics's total emissions were approximately 32,174,000 kg CO2e, comprising Scope 1 emissions of about 689,000 kg CO2e, Scope 2 market-based emissions of roughly 8,126,000 kg CO2e, and Scope 3 emissions of approximately 17,720,000 kg CO2e. The company has also reported Scope 1 and Scope 2 emissions for earlier years: for 2022, Scope 1 emissions were around 588,100 kg CO2e and Scope 2 emissions were approximately 9,109,500 kg CO2e; for 2021, Scope 1 emissions were about 508,200 kg CO2e and Scope 2 emissions were around 7,028,800 kg CO2e; and for 2020, Scope 1 emissions were roughly 432,700 kg CO2e and Scope 2 emissions were about 6,716,500 kg CO2e. No emissions data is available for 2023.
Integral Diagnostics has not publicly disclosed any specific carbon reduction targets, such as Science Based Targets Initiative (SBTi) commitments or other documented reduction initiatives.
No climate goals have been disclosed for Integral Diagnostics yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more